Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease.
Juan Francisco Navarro-GonzálezMaría Dolores Sánchez-NiñoJavier Donate-CorreaErnesto Martín-NúñezCarla FerriNayra Pérez-DelgadoJosé Luis GórrizAlberto Martínez-CastelaoAlberto OrtizCarmen Mora-FernándezPublished in: Diabetes care (2018)
Pentoxifylline increased Klotho levels in patients with diabetes with stage 3-4 CKD and prevented reduced Klotho expression in vitro. This beneficial effect may be related to anti-inflammatory and antialbuminuric activity.